VRTX
#124
Vertex Pharmaceuticals Incorporated - Common Stock
485.3 9 USD
-0.04%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-4.26%
Changement Mensuel
-7.04%
Evolution sur 6 mois
+11.51%
Changement Annuel
+19.53%
Clôture Précédente
507.0 0
Open
507.5 5
Low
484.0 8
High
508.5 7
Financials
- Market Capitalization 123.03 B
- Employee 6 400
- Founded 1989
- CEO Reshma Kewalramani
- Website www.vrtx.com
- Headquarter Massachusetts, United States
- FIGI BBG000C1S2X2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
29.59
ratio cours/chiffre d'affaires
9.75
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 192 |  MRNA Moderna, Inc. - Common Stock | 216.25 USD | +1.17% | +18.16% | +49.14% | +721.31% | 86.33 B USD | ||
| 217 |  REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 753.12 USD | -1.27% | +2.04% | -4.55% | +35.23% | 77.54 B USD | ||
| 314 |  ARGX argenx SE - American Depositary Shares | 802.64 USD | -1.19% | -13.89% | -20.10% | +0.49% | 49.67 B USD | ||
| 364 |  RVMD Revolution Medicines, Inc. - Common Stock | 188.53 USD | -2.79% | -5.67% | -7.36% | +240.31% | 40.41 B USD |